These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 31057482)

  • 1. Updates on Osteoimmunology: What's New on the Cross-Talk Between Bone and Immune System.
    Ponzetti M; Rucci N
    Front Endocrinol (Lausanne); 2019; 10():236. PubMed ID: 31057482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoimmunology.
    Rauner M; Sipos W; Pietschmann P
    Int Arch Allergy Immunol; 2007; 143(1):31-48. PubMed ID: 17191007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic insight into osteoclast differentiation in osteoimmunology.
    Takayanagi H
    J Mol Med (Berl); 2005 Mar; 83(3):170-9. PubMed ID: 15776286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory bone destruction and osteoimmunology.
    Takayanagi H
    J Periodontal Res; 2005 Aug; 40(4):287-93. PubMed ID: 15966905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.
    Liu XH; Kirschenbaum A; Yao S; Levine AC
    Endocrinology; 2005 Apr; 146(4):1991-8. PubMed ID: 15618359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoclasts, rheumatoid arthritis, and osteoimmunology.
    Sato K; Takayanagi H
    Curr Opin Rheumatol; 2006 Jul; 18(4):419-26. PubMed ID: 16763464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.
    Suda T; Takahashi N; Udagawa N; Jimi E; Gillespie MT; Martin TJ
    Endocr Rev; 1999 Jun; 20(3):345-57. PubMed ID: 10368775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New immune connections in osteoclast formation.
    Takayanagi H
    Ann N Y Acad Sci; 2010 Mar; 1192():117-23. PubMed ID: 20392226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems.
    Okamoto K; Nakashima T; Shinohara M; Negishi-Koga T; Komatsu N; Terashima A; Sawa S; Nitta T; Takayanagi H
    Physiol Rev; 2017 Oct; 97(4):1295-1349. PubMed ID: 28814613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons.
    Llorente I; García-Castañeda N; Valero C; González-Álvaro I; Castañeda S
    Front Med (Lausanne); 2020; 7():601618. PubMed ID: 33330566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between bone niche and immune system: osteoimmunology signaling as a potential target for cancer treatment.
    Criscitiello C; Viale G; Gelao L; Esposito A; De Laurentiis M; De Placido S; Santangelo M; Goldhirsch A; Curigliano G
    Cancer Treat Rev; 2015 Feb; 41(2):61-8. PubMed ID: 25499997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Osteoimmunology' Offers New Perspectives for the Treatment of Pathological Bone Loss.
    Liu H; Luo T; Tan J; Li M; Guo J
    Curr Pharm Des; 2017; 23(41):6272-6278. PubMed ID: 28494718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatoid arthritis and osteoimmunology: The adverse impact of a deregulated immune system on bone metabolism.
    Andreev D; Kachler K; Schett G; Bozec A
    Bone; 2022 Sep; 162():116468. PubMed ID: 35688359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoimmunology: Influence of the Immune System on Bone Regeneration and Consumption.
    Limmer A; Wirtz DC
    Z Orthop Unfall; 2017 Jun; 155(3):273-280. PubMed ID: 28683495
    [No Abstract]   [Full Text] [Related]  

  • 15. Concise Review: Stem Cells in Osteoimmunology.
    Fierro FA; Nolta JA; Adamopoulos IE
    Stem Cells; 2017 Jun; 35(6):1461-1467. PubMed ID: 28390147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between the immune system and bone metabolism: an emerging field of osteoimmunology.
    Takayanagi H
    Proc Jpn Acad Ser B Phys Biol Sci; 2007 Jun; 83(5):136-43. PubMed ID: 24019592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoprotegerin and inflammation.
    Saidenberg Kermanac'h N; Bessis N; Cohen-Solal M; De Vernejoul MC; Boissier MC
    Eur Cytokine Netw; 2002; 13(2):144-53. PubMed ID: 12101070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in the regulation of bone remodeling at the cellular level].
    Hu Y; Wang L; Jiang L; Xu H; Zhu S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2017 Jun; 34(3):471-479. PubMed ID: 29745517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel functions of RANK(L) signaling in the immune system.
    Leibbrandt A; Penninger JM
    Adv Exp Med Biol; 2010; 658():77-94. PubMed ID: 19950018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.